Skip to content

Motor Imagery and Action Observation for Gait Function in MS

Effects of Motor Imagery and Action Observation on Gait Initiation and Spatiotemporal Gait Parameters in Multiple Sclerosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07137624
Enrollment
20
Registered
2025-08-22
Start date
2026-01-03
Completion date
2026-09-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Motor imagery, Action Observation

Brief summary

This study will investigate whether mentally simulating walking movements while watching others walk can improve walking performance in individuals with Multiple Sclerosis (MS). Participants will be divided into two groups: one group will watch walking videos and imagine themselves walking, while the other group will watch nature scenes. The study will measure muscle activity and walking patterns to assess the effects. The results may help support the use of mental practice techniques to improve mobility in people with MS.

Detailed description

This study aims to explore the impact of mental simulation of walking movements on walking performance in individuals with Multiple Sclerosis (MS). The participants will be randomly assigned to two groups: the experimental group will watch walking-related videos and engage in mental imagery exercises, imagining themselves walking, while the control group will watch nature scenes without any walking-related content. Objectives: To determine whether mental imagery can enhance walking ability and gait parameters in individuals with MS. To measure the effect of mental simulation on muscle activity and walking patterns, including stride length, walking speed, and balance. Study Procedure: The study will consist of multiple sessions, where participants will first undergo baseline assessments of walking ability. Following this, they will engage in either the walking video and imagery task (experimental group) or the nature video viewing task (control group) for a predetermined period of time. Measurements of muscle activity using electromyography (EMG) and walking patterns will be recorded before and after the intervention. Potential Impact: The results from this study may provide insights into the use of mental practice techniques as a non-invasive intervention to improve mobility in individuals with MS, a population often affected by walking difficulties. Mental imagery could serve as an adjunct therapy to traditional physical rehabilitation methods.

Interventions

Participants will watch videos showing walking actions and will be instructed to mentally simulate the movement.

BEHAVIORALNature Video

Participants will watch a video of nature scenes.

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

The study will be single-blinded. Participants will not be informed of their group assignment.

Intervention model description

Participants will be randomly assigned to either the experimental group (motor imagery + action observation) or the control group (nature video).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* A confirmed diagnosis of multiple sclerosis (MS) by a neurologist * No history of relapse within the past 3 months and not currently experiencing a relapse * A score of 24 or higher on the standardized Mini Mental State Examination

Exclusion criteria

* Presence of serious health conditions affecting the muscles, heart, lungs, or metabolism that could interfere with participation * History of other neurological disorders, head injury, or chronic psychiatric conditions * Chronic pain lasting longer than six months * Significant muscle stiffness in the legs that may affect EMG recordings * Hearing difficulties * Vision problems as determined by the Snellen visual acuity test

Design outcomes

Primary

MeasureTime frameDescription
Change in Tibialis Anterior and Gastrocnemius Medialis Muscle Activity AmplitudeBefore and immediately after the interventionChange in muscle activity amplitude (microvolts, µV) of tibialis anterior and gastrocnemius medialis during gait initiation measured by surface EMG.
Change in Tibialis Anterior and Gastrocnemius Medialis Muscle Activity Onset LatencyBefore and immediately after the intervention.Change in onset latency (milliseconds, ms) of tibialis anterior and gastrocnemius medialis muscle activation during gait initiation measured by surface EMG.
Change in Step LengthBefore and immediately after the interventionChange in step length (centimeters, cm) during gait initiation measured by the GAITRite system.
Change in Step TimeBefore and immediately after the interventionChange in step time (seconds, s) during gait initiation measured by the GAITRite system.
Change in Step WidthBefore and immediately after the interventionChange in step width (centimeters, cm) during gait initiation measured by the GAITRite system.
Change in Double Support PeriodBefore and immediately after the interventionChange in double support period (percentage of gait cycle, %) during gait initiation measured by the GAITRite system.
Change in Gait VelocityBefore and immediately after the interventionChange in gait velocity (centimeters per second, cm/s) during gait initiation measured by the GAITRite system.
Change in CadenceBefore and immediately after the interventionChange in cadence (steps per minute, steps/min) during gait initiation measured by the GAITRite system.

Secondary

MeasureTime frameDescription
Motor Imagery VividnessBaseline onlyKinesthetic and visual imagery vividness will be assessed using the Kinesthetic and Visual Imagery Questionnaire-20 (KVIQ-20), which includes 10 visual and 10 kinesthetic items (20 total). Each item is rated on a 5-point Likert scale (1 = no image/sensation, 5 = vivid image/sensation). Higher scores indicate better imagery ability.
Mental Chronometry RatioBaseline onlyThe ratio between imagined and actual Timed Up and Go (TUG) performance time (both measured in seconds, s) will be calculated. During imagined trials, participants will press a button to mark the start and end of the imagined movement sequence. A ratio closer to 1 indicates better temporal congruence between imagined (iTUG) and executed TUG performance.
Limb Laterality Recognition PerformanceBaseline onlyRight-left discrimination ability will be evaluated using the Recognise Foot App™ developed by the NOI Group™. Both accuracy (percentage of correct responses, %) and response time (milliseconds, ms) will be recorded.
Cognitive StatusBaseline onlyGeneral cognitive functioning will be screened using the Standardized Mini-Mental State Examination (SMMSE). The test is scored on a 30-point scale (0-30). Scores ≥24 indicate normal cognitive functioning.
Fatigue LevelBaseline onlyFatigue severity specific to MS will be measured with the Fatigue Severity Scale (FSS). The FSS consists of 9 items rated on a 7-point Likert scale (1 = strongly disagree; 7 = strongly agree). The final score is calculated as the mean of all items (range: 1-7), with higher scores indicating greater fatigue severity.
Anxiety and DepressionBaseline onlyEmotional state will be assessed using the Hospital Anxiety and Depression Scale (HADS). The scale consists of 14 items divided into two subscales: anxiety (7 items) and depression (7 items). Each item is scored from 0 to 3, yielding subscale scores ranging from 0 to 21. Higher scores indicate greater levels of anxiety or depression.
Disability LevelBaseline onlyExpanded Disability Status Scale (EDSS) scoring will be performed using the standardized Neurostatus-EDSS format. This scale evaluates functional systems such as motor ability, balance, vision, and sensory function to quantify disability level in individuals with multiple sclerosis. Scores range from 0 to 10 in 0.5-point increments, where 0 indicates normal neurological status and 10 represents death due to MS. Higher scores reflect greater disability.
Visual AcuityBaseline onlyParticipants' visual acuity will be assessed using the Snellen chart under standard conditions. The test will be conducted with or without corrective lenses depending on the participant's usual visual aid usage. Visual acuity will be recorded as a Snellen fraction (e.g., 20/20, 20/40), where larger denominators indicate poorer visual performance.

Countries

Turkey (Türkiye)

Contacts

CONTACTMerve Ünal, Res. Asst.
merveunal.144@gmail.com+905386582787
STUDY_CHAIRYeliz Salcı, Assoc. Prof.

Hacettepe University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026